Atlas Trials

Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial

Clinical trial NCT04942002 · UNKNOWN

Trial details

NCT number
NCT04942002
Sponsor
Asociación para Evitar la Ceguera en México
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Optic NeuritisTreatmentMethylprednisolone
Start date
2021-06-15
Primary completion
2023-06-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.